Angioedema
Allergy, immunology mourns the loss of Marcus Maurer, MD
Allergy and immunology lost a pioneer last summer with the death of Marcus Maurer, MD, executive director of the Institute of Allergology at Charité University Medicine, Berlin.
Patient experiences angioedema with pembrolizumab treatment
BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.
Hereditary angioedema attacks fall nearly 95% with lanadelumab among adolescents
Adolescents with hereditary angioedema experienced fewer attacks, improved quality of life and treatment satisfaction with lanadelumab, according to a study published in Annals of Allergy, Asthma & Immunology.
Patients with chronic urticaria who stop omalizumab often do so after treatment success
Omalizumab is effective and safe for the treatment of chronic urticaria, demonstrating high discontinuation due to well-controlled disease, according to a study.
Pediatric egg-induced anaphylaxis may present differing symptoms than other food allergies
Children experiencing egg-induced anaphylaxis may be seeing certain symptoms that differentiate them from other food-induced anaphylaxis, according to a study published in Annals of Allergy, Asthma and Immunology.
Donidalorsen may reduce hereditary angioedema attack rates
Donidalorsen trials showed positive results in treating patients with hereditary angioedema, exhibiting significant reductions in attack rates, according to a study published in The New England Journal of Medicine.
Urticarial Vasculitis: Attack of the Nettles, Part 1
Is it an allergy or an autoimmune vasculitis, or a little of both? Find out the story of urticarial vasculitis, how this disease was recognized and eventually sorted out from other types of urticaria.
Standardized guidelines improve management of urticaria in ED
ANAHEIM, Calif. — A quality-improvement initiative helped close knowledge gaps on the treatment of urticaria in the ED, according to study results presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
COVID-19 vaccination safe in children with prior reactions, pre-existing conditions
Children with a history of allergy to COVID-19 vaccines or pre-existing conditions that put them at higher risk for a reaction safely tolerated testing and challenges, according to a letter published in Clinical and Translational Allergy.
7-day Urticaria Control Test scores correlate with results from 4-week version
The UCT7 reduces the Urticaria Control Test’s 4-week recall period to 7 days to assess disease control at short intervals in clinical studies and practice, according to a study published in The Journal of Allergy and Clinical Immunology.